Ihuman Operating Cycle from 2010 to 2026

IH Stock  USD 1.83  0.01  0.55%   
Ihuman's Operating Cycle is decreasing with slightly volatile movements from year to year. Operating Cycle is estimated to finish at 98.18 this year. For the period between 2010 and 2026, Ihuman, Operating Cycle quarterly trend regression had mean deviation of  64.46 and range of 159. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
59.55
Current Value
98.18
Quarterly Volatility
69.1882738
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 11.2 M, Depreciation And Amortization of 16.5 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 0.15, Dividend Yield of 0.26 or PTB Ratio of 0.13. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Build AI portfolio with Ihuman Stock
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Ihuman Inc over the last few years. It is Ihuman's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Ihuman Operating Cycle Regression Statistics

Arithmetic Mean141.05
Geometric Mean121.12
Coefficient Of Variation49.05
Mean Deviation64.46
Median201.93
Standard Deviation69.19
Sample Variance4,787
Range159
R-Value(0.87)
Mean Square Error1,273
R-Squared0.75
Slope(11.87)
Total Sum of Squares76,592

Ihuman Operating Cycle History

2026 98.18
2025 59.55
2024 51.78
2023 42.77
2022 54.05
2021 58.83
2020 90.72

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 59.55  98.18 

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.11)
Earnings Share
0.28
Revenue Per Share
16.441
Quarterly Revenue Growth
(0.14)
Return On Assets
0.0326
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.